Studies suggest that other human coronaviruses may induce cross-immunity to SARS-CoV-2. Accordingly, we developed PepMixes™ and Epitope Mapping Peptide Sets (EMPS) of Spike Glycoproteins for other relevant coronaviruses to evaluate cross reactive T-cell responses and identify immune dominant regions:
PepMix™ forSARS-CoV-2, SARS, MERS and seasonal coronaviruses 229E, NL63, OC43 and HKU1
EMPS forSARS-CoV-2, SARS, MERS and seasonal coronaviruses 229E, NL63, OC43 and HKU1
PepMix™ Peptide Pools contain overlapping peptides spanning the entire antigen. Corresponding EMPS contain both Matrix Pools and individual overlapping peptides for the detection of specific T-cell epitopes.
Please contact us so that we can learn more about your research. Let us partner to continue the fight against COVID-19.